Artificial white light photodynamic therapy for actinic keratosis: a study of 38 patients in private office practice.
Photodynamic therapy (PDT) using daylight as the photoactivating light source requires weather conditions and temperature to be suitable for effective treatment and for patients to stay comfortably outdoors. In order to get rid of such requirements, artificial white light sources have been proposed as photoactivating alternatives to daylight, particularly for the treatment of actinic keratosis (AK). Such is the case of Dermaris (Surgiris, Croix, France), a new CE-marked device specifically designed for the treatment of AK, which delivers a uniform illumination with 2.9 mW/cm2 white light over a 314 cm2 surface.